Science

Ivermectin: balance of evidence shows no benefit against Covid-19

While it’s too soon to say that the drug is useless, it has clearly been overhyped

Alcohol bans reduced deaths, study finds

UCT and MRC researchers found that dozens of deaths a day were averted by restrictions

The EFF wants us to use the Russian and Chinese vaccines. But there are unanswered questions about them

The regulatory authority must act in the public interest and not be swayed by undue pressure

Tim Noakes and BizNews are spreading dangerous falsehoods

They have misrepresented Anthony Fauci’s correspondence and cast aspersions on Glenda Gray

Africa has a higher death rate among critically ill Covid-19 patients than anywhere else

The death rate was 48% compared to the global average of 32%

Covid-19 in South Africa: 150,000 excess deaths in one year

The problem with pausing a vaccine rollout

Interrupting a programme early leads to many more infections than one might naively estimate

Report shows dangerous levels of pollution in Cape Town’s rivers, vleis and estuaries

Quality of water bodies has declined over 40 years

Covid-19 has hit pregnant women hard

Researchers find higher rates of still births and maternal deaths

Should we have another tough lockdown? Not yet

Starting a lockdown too early or too late reduces the benefits but not the hardships

Top scientists slam government for not using AstraZeneca vaccines

“South Africa has squandered the opportunity to protect half a million of its most vulnerable citizens”

Leading research institute says there should be no new trials of hydroxychloroquine for Covid

The drug has failed to prevent or treat the disease, and it has lots of side-effects

Cape Town’s sewers offer clues to next Covid-19 wave

Waste treatment plants across the city are being monitored weekly

Ivermectin study boosts regulator’s court defence

The first substantial peer-reviewed clinical trial of the drug against Covid-19 finds no evidence that it is a wonder medicine

Covid-19: Scientists reveal good news about variant discovered in South Africa

If you have antibodies to the 501Y.V2 variant, you likely have protection against other strains of the virus

Johnson & Johnson vaccine looks excellent for South Africa in first published detailed analysis

Concern raised about missed production target, but Professor Glenda Gray says it’s a well-oiled company and they know what they have to do